+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

POC HbA1C Testing Market Opportunities and Strategies to 2033

  • PDF Icon

    Report

  • 293 Pages
  • January 2025
  • Region: Global
  • The Business Research Company
  • ID: 5805659
This report describes and explains the POC HbA1C testing market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global POC HbA1C testing market reached a value of nearly $842.91 million in 2023, having grown at a compound annual growth rate (CAGR) of 7.77% since 2018. The market is expected to grow from $842.91 million in 2023 to $1.44 billion in 2028 at a rate of 11.45%. The market is then expected to grow at a CAGR of 10.96% from 2028 and reach $2.43 billion in 2033.

Growth in the historic period resulted from an increase in disposable income, rising adoption of personalized medicine and healthcare infrastructure improvements. Factors that negatively affected growth in the historic period were the development of alternative blood monitoring methods.

Going forward, rising prevalence of diabetes, expanding geriatric population, strong economic growth in emerging markets, rise in government support and regulatory support and reimbursement policies will drive the growth. Factor that could hinder the growth of the POC HbA1C testing market in the future include lack of trained healthcare professionals.

The POC HbA1C testing market is segmented by type of product into instruments and consumables. The consumables market was the largest segment of the POC HbA1C testing market segmented by type of product, accounting for 58.2% or $490.65 million of the total in 2023. Going forward, the consumables segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by type of product, at a CAGR of 12.23% during 2023-2028.

The POC HbA1C testing market is segmented by technology into ion-exchange HPLC, enzymatic assay affinity binding and immunoassay. The immunoassay market was the largest segment of the POC HbA1C testing market segmented by technology, accounting for 35.8% or $301.37 million of the total in 2023. Going forward, the immunoassay segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by technology, at a CAGR of 12.53% during 2023-2028.

The POC HbA1C testing market is segmented by end user into hospitals, physician office/outpatient center, home care and other end users. The hospitals market was the largest segment of the POC HbA1C testing market segmented by end user, accounting for 42.8% or $361.06 million of the total in 2023. Going forward, the home care segment is expected to be the fastest growing segment in the POC HbA1C testing market segmented by end user, at a CAGR of 13.76% during 2023-2028.

North America was the largest region in the POC HbA1C testing market, accounting for 37% or $312.23 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the POC HbA1C testing market will be North America and Western Europe where growth will be at CAGRs of 12.76% and 11.62% respectively. These will be followed by Asia-Pacific and South America where the markets are expected to grow at CAGRs of 10.40% and 10.08% respectively.

The global POC HbA1C testing market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up 81.2% of the total market in 2023. Siemens Healthineers AG was the largest competitor with a 17.5% share of the market, followed by F. Hoffmann-La Roche AG with 12.9%, Bio-Rad Laboratories, Inc. with 12.4%, Menarini Group with 11.3%, Danaher Corporation with 9.1%, i-SENS, Inc. with 5.7%, Tosoh Corp. with 5%, ARKRAY Inc. with 4.4%, Abbott Laboratories with 2% and LumoraDX with 0.9%.

The top opportunities in the POC HbA1C testing market segmented by type of product will arise in the consumables segment, which will gain $383.02 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by technology will arise in the immunoassay segment, which will gain $242.52 million of global annual sales by 2028. The top opportunities in the POC HbA1C testing market segmented by end user will arise in the physician office/outpatient center segment, which will gain $244.9 million of global annual sales by 2028The POC HbA1C testing market size will gain the most in the USA at $223.89 million.

Market-trend-based strategies for the POC HbA1C testing market include focus on advanced point-of-care solution for rapid and accurate HbA1C testing, launch of next-generation point-of-care device enhances diabetes management and early diagnosis, FDA approval for innovative point-of-care HbA1C testing system using menstrual blood and strategic partnerships and acquisition among major players to enhance product offerings.

Player-adopted strategies in the POC HbA1C testing market include focuses on strengthening its business operations through strategic partnerships and new product launches to expand their business expertise.

To take advantage of the opportunities, the analyst recommends the POC HbA1C testing companies to focus on enhancing multi-parameter testing solutions, focus on enhancing efficiency and adoption of advanced POC devices, focus on product innovation and patient convenience, focus on consumables market growth for POC hba1c testing companies, focus on immunoassay market growth for POC hba1c testing companies, expand in emerging markets, focus on expanding distribution channels through strategic partnerships, focus on pricing strategies to enhance competitive positioning, focus on targeted marketing to healthcare providers, focus on digital channels and patient awareness and focus on hospitals to enhance adoption of POC hba1c testing.

Table of Contents

1. Executive Summary
1.1 POC HbA1C Testing - Market Attractiveness and Macro economic Landscape
2. Table of Contents3. List of Tables4. List of Figures5. Report Structure
6. Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 POC HbA1C Testing Market Definition and Segmentations
6.4 Market Segmentation by Type of Product
6.4.1 Instruments
6.4.2 Consumables
6.5 Market Segmentation by Technology
6.5.1 Ion-Exchange HPLC
6.5.2 Enzymatic Assay
6.5.3 Affinity Binding
6.5.4 Immunoassay
6.6 Market Segmentation by End User
6.6.1 Hospitals
6.6.2 Physician Office/Outpatient Center
6.6.3 Home Care
6.6.4 Other End Users
7. Major Market Trends
7.1 Advanced Point-of-Care Solution For Rapid and Accurate HbA1C Testing
7.2 Launch of Next-Generation Point-of-Care Device Enhances Diabetes Management and Early Diagnosis
7.3 FDA Approval For Innovative Point-of-Care HbA1C Testing System Using Menstrual Blood
7.4 Strategic Partnerships and Acquisition Among Major Players to Enhance Product Offerings
8. POC HbA1C Testing Market - Macro-Economic Scenario
8.1 COVID-19 Impact on the POC HbA1C Testing Market
8.2 Impact of the War in Ukraine on the POC HbA1C Testing Market
8.3 Impact of High Inflation on the POC HbA1C Testing Market
9. Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018-2023, Value ($ Million)
9.2.1 Market Drivers 2018-2023
9.2.2 Market Restraints 2018-2023
9.3 Forecast Market Growth, 2023-2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023-2028
9.3.2 Market Restraints 2023-2028
10. Global POC HbA1C Testing Market Segmentation
10.1 Global POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.2 Global POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.3 Global POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11. POC HbA1C Testing Market, Regional and Country Analysis
11.1 Global POC HbA1C Testing Market, by Region, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11.2 Global POC HbA1C Testing Market, by Country, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12. Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific POC HbA1C Testing Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.9 China POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.1 China POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.13 India POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.14 India POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.17 Japan POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.18 Japan POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.2 Australia POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.21 Australia POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.22 Australia POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.3 South Korea POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13. Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe POC HbA1C Testing Market: Country Analysis
13.6 UK Market
13.7 UK POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.8 UK POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.9 UK POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.1 Germany Market
13.11 Germany POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.12 Germany POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.13 Germany POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.16 France POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.17 France POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.2 Italy POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.21 Italy POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.24 Spain POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.25 Spain POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14. Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major companies
14.2 Eastern Europe POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe POC HbA1C Testing Market: Country Analysis
14.6 Russia Market
14.7 Russia POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.8 Russia POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.9 Russia POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15. North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.3 North America POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.4 North America POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.5 North America POC HbA1C Testing Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.9 USA POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.1 USA POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.13 Canada POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.14 Canada POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16. South America Market
16.1 Summary
16.1.1 Market Overview
16.1.1 Region Information
16.1.2 Market Information
16.1.3 Background Information
16.1.4 Government Initiatives
16.1.5 Regulations
16.1.6 Regulatory Bodies
16.1.7 Major Associations
16.1.8 Taxes Levied
16.1.9 Corporate Tax Structure
16.1.10 Investments
16.1.11 Major Companies
16.2 South America POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.3 South America POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.4 South America POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.5 Brazil Market
16.6 Brazil POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.7 Brazil POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17. Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18. Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa POC HbA1C Testing Market, Segmentation by Type of Product, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.3 Africa POC HbA1C Testing Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.4 Africa POC HbA1C Testing Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
19. Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Siemens Healthineers AG
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 F. Hoffman-La Roche Ltd
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Bio-Rad Laboratories, Inc
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Financial Overview
19.5 Menarini Group
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Danaher Corporation
19.6.1 Company Overview
19.6.2 Products and Services
19.6.3 Financial Overview
20. Other Major and Innovative Companies
20.1 i-SENS, Inc
20.1.1 Company Overview
20.1.2 Products and Services
20.2 Tosoh Corp
20.2.1 Company Overview
20.2.2 Products and Services
20.3 ARKRAY Inc
20.3.1 Company Overview
20.3.2 Products and Services
20.4 Abbott Laboratories
20.4.1 Company Overview
20.4.2 Products and Services
20.5 LumoraDX
20.5.1 Company Overview
20.5.2 Products and Services
20.6 PTS Diagnostics
20.6.1 Company Overview
20.6.2 Products and Services
20.7 EKF Diagnostics
20.7.1 Company Overview
20.7.2 Products and Services
20.8 SD Biosensor
20.8.1 Company Overview
20.8.2 Products and Services
20.9 Getein Biotech Inc
20.9.1 Company Overview
20.9.2 Products and Services
20.1 Sysmex Corporation
20.10.1 Company Overview
20.10.2 Products and Services
20.11 Diazyme Laboratories
20.11.1 Company Overview
20.11.2 Products and Services
20.12 HUMAN Diagnostics Worldwide
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Trinity Biotech PLC
20.13.1 Company Overview
20.13.2 Products and Services
20.14 Randox Laboratories Ltd
20.14.1 Company Overview
20.14.2 Products and Services
20.15 Osang Healthcare
20.15.1 Company Overview
20.15.2 Products and Services
21. Competitive Benchmarking22. Competitive Dashboard
23. Key Mergers and Acquisitions
23.1 Roche Holding AG Acquired LumiraDx
23.2 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
23.3 QIAGEN N.V. Acquired BLIRT S.A.
24. Opportunities and Strategies
24.1 Global POC HbA1C Testing Market in 2028 - Countries Offering Most New Opportunities
24.2 Global POC HbA1C Testing Market in 2028 - Segments Offering Most New Opportunities
24.3 Global POC HbA1C Testing Market in 2028 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25. POC HbA1C Testing Market, Conclusions and Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26. Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 About the Analyst
26.6 Copyright and Disclaimer

Executive Summary

POC HbA1c Testing Global Market Opportunities And Strategies To 2032 provides the strategists; marketers and senior management with the critical information they need to assess the global POC HbA1c testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest-growing market for POC HbA1c testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POC HbA1c testing market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider POC HbA1c testing market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the POC HbA1c testing market.
  • Key Trends
Highlights the major trends shaping the global POC HbA1c testing market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
  • Market Segmentation
Contains the market values (2017-2032) and analysis for segment by type of product, by technology and by end user in the market.
  • Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations
This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for POC HbA1c testing providers in terms of product offerings, geographic expansion, price offerings, and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type Of Product: Instruments; Consumables
2) By Technology: Ion-Exchange HPLC; Enzymatic Assay; Affinity Binding Chromatography; Immunoassay; Other Technologies
3) By End User: Hospitals; Physician Office/Outpatient Center; Home Care; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd; Siemens Healthineers AG; Bio-Rad Laboratories, Inc; Menarini Group; Danaher Corporation

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POC HbA1c testing indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • Siemens Healthineers AG
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Menarini Group
  • Danaher Corporation
  • i-SENS, Inc.
  • Tosoh Corp.
  • ARKRAY Inc.
  • Abbott Laboratories
  • LumoraDX
  • Roche Diagnostics
  • Hipro Biotechnology
  • Osang HealthCare Co Ltd.
  • PTS Diagnostics
  • bioMérieux
  • Rapid Diagnostic Pvt. Ltd.
  • CPC Diagnostics Pvt. Ltd.
  • Agappe Diagnostic Ltd.
  • Transasia Bio-Medicals Ltd.
  • Nipro Corp
  • Sekisui Medical Co. Ltd.
  • HemoCue AB
  • Achira Labs Pvt. Ltd.
  • AccuBioTech Co., Ltd.
  • Molbio Diagnostics Pvt. Ltd.
  • Getein Biotech
  • SugenTech Inc.
  • Trinity Biotech plc.
  • EKF Diagnostics
  • A.Menarini Diagnostics Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Novo Nordisk
  • QIAGEN N.V.
  • Curiosity Diagnostics
  • Switch Health
  • Qvin
  • ACON Laboratories
  • Precision Diabetes Inc.
  • Echo Therapeutics, Inc.
  • LifeLabs
  • Quidel Corporation
  • Nova Biomedical
  • Diazyme Laboratories
  • Alere
  • Grupo Biolab
  • AstraZeneca
  • Ortho Clinical Diagnostics
  • Tamer
  • BioTeknica
  • Biotech Pars
  • Ascensia
  • Platinum Equity (LifeScan)
  • BAMCO Africa
  • Kainico Ltd.
  • Evia Medical Technologies
  • Medtronic
  • Agamatrix Inc.
  • Bionime Corporation
  • B Braun Melsungen AG

Table Information